HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jonathan Kay Selected Research

Jonathan Kay Research Topics

Disease

15Nephrogenic Fibrosing Dermopathy
11/2015 - 10/2007
11Rheumatoid Arthritis
03/2015 - 04/2008
8Kidney Diseases (Kidney Disease)
11/2015 - 07/2008
5Inflammation
11/2015 - 05/2010
4Fibrosis (Cirrhosis)
11/2015 - 07/2008
4Infection
06/2015 - 03/2002
4Ankylosing Spondylitis
06/2015 - 01/2009
4Necrosis
03/2015 - 07/2009
3Psoriatic Arthritis
03/2015 - 01/2009
2Prostatic Neoplasms (Prostate Cancer)
06/2015 - 04/2015
2Neoplasms (Cancer)
04/2015 - 11/2006
1Neutropenia
06/2015
1Lymphoma (Lymphomas)
03/2015
1Tuberculosis (Tuberculoses)
03/2015
1Opportunistic Infections (Opportunistic Infection)
03/2015
1Demyelinating Diseases (Demyelinating Disease)
03/2015
1Autoimmune Diseases (Autoimmune Disease)
07/2013
1Arthritis (Polyarthritis)
05/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2013
1Systemic Scleroderma (Systemic Sclerosis)
03/2013
1Rheumatic Diseases (Rheumatism)
12/2012
1Patent Foramen Ovale
10/2012
1Cardiomyopathies (Cardiomyopathy)
10/2012
1Sensorineural Hearing Loss
02/2012
1Tenosynovitis
11/2010
1Diabetes Complications
11/2010
1Bursitis (Adhesive Capsulitis)
11/2010
1Acute-Phase Reaction
09/2010
1Hyperparathyroidism
12/2009
1Dextrocardia
12/2008
1Transposition of Great Vessels (Great Vessels Transposition)
12/2008
1Contracture
08/2008
1Hyperpigmentation
10/2007
1Pheochromocytoma
11/2006
1Wegener Granulomatosis (Wegener's Granulomatosis)
08/2006
1Osteoarthritis
02/2003
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2002
1Viremia
03/2002
1Cryoglobulinemia
03/2002
1Trisomy (Trisomies)
03/2002

Drug/Important Bio-Agent (IBA)

14GadoliniumIBA
11/2015 - 10/2007
9golimumabFDA Link
03/2015 - 04/2008
8Contrast MediaIBA
11/2015 - 07/2008
5Methotrexate (Mexate)FDA LinkGeneric
03/2015 - 04/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2015 - 01/2009
2InterleukinsIBA
11/2015 - 05/2010
2Interleukin-6 (Interleukin 6)IBA
06/2015 - 05/2010
2CytokinesIBA
12/2012 - 05/2010
2imatinib (Gleevec)FDA Link
02/2012 - 08/2008
1AsbestosIBA
11/2015
1Silicon Dioxide (Sand)FDA LinkGeneric
11/2015
1corrigendumIBA
06/2015
1Alanine Transaminase (SGPT)IBA
06/2015
1DNA (Deoxyribonucleic Acid)IBA
04/2015
1decitabine (5-aza-2'-deoxycytidine)FDA Link
04/2015
1Ferritins (Ferritin)IBA
10/2013
1rituximab (Mabthera)FDA Link
07/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2013
1Adrenal Cortex Hormones (Corticosteroids)IBA
05/2013
1Antinuclear AntibodiesIBA
03/2013
1acetyl 4-aminosalicylic acidIBA
12/2012
1CreatinineIBA
04/2011
1Eosine Yellowish-(YS) (Eosin)IBA
04/2011
1Hematoxylin (Haematoxylon)IBA
04/2011
1Insulin (Novolin)FDA Link
04/2011
1AdipokinesIBA
11/2010
1Glucose (Dextrose)FDA LinkGeneric
11/2010
1C-Reactive ProteinIBA
09/2010
1AntibodiesIBA
09/2010
1Interleukin-17 (Interleukin 27)IBA
05/2010
1gadobenic acid (gadobenate dimeglumine)FDA Link
12/2009
1Parathyroid Hormone (Parathormone)IBA
12/2009
1Gadolinium DTPA (Magnevist)FDA Link
10/2009
1Biological Markers (Surrogate Marker)IBA
07/2009
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
07/2009
1Interleukin-18 (Interleukin 18)IBA
07/2009
1E-SelectinIBA
07/2009
1Serum Amyloid A Protein (Serum Amyloid A)IBA
07/2009
1Collagen Type I (Type I Collagen)IBA
08/2008
1CatecholaminesIBA
11/2006
1N-nitroso-N-methyltyramine (NNMT)IBA
11/2006
1MetanephrineIBA
11/2006
1pentosidineIBA
02/2003
1Interferon-alpha (Interferon Alfa)FDA Link
03/2002
1Rheumatoid FactorIBA
03/2002

Therapy/Procedure

3Aftercare (After-Treatment)
01/2015 - 03/2002
3Biological Therapy
08/2011 - 08/2006
2Renal Dialysis (Hemodialysis)
07/2008 - 10/2007
1Anesthesia
10/2012
1Subcutaneous Injections
07/2009
1Heart Transplantation (Grafting, Heart)
12/2008